ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 431,04
-0,79%
Dow Jones
41 938,45
-1,63%
DAX
20 214,79
-0,51%
Brent Oil
79,285
0,00%
Bitcoin
94 165,47
-0,43%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Brainstorm Cell Therapeutics Inc (BCLI)

  7. Brainstorm Cell Therapeutics Inc (BCLI) Actualités

BCLI

Brainstorm Cell Therapeu... (BCLI)

Brainstorm Cell Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BCLI
DateHeureSourceTitreSymboleSociété
07/01/202522h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
07/01/202522h10Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202422h40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202421h24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
30/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
24/09/202422h30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
17/09/202421h32Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202413h03Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202413h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
06/08/202422h59Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
05/08/202423h11Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
31/07/202422h09Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
24/07/202414h30PR Newswire (Canada)BCLI Update - Progress Supports Our 10x Plus Value Range PotentialNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/06/202418h01PR Newswire (US)BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness ExpectationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
27/02/202412h30PR Newswire (US)BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific ConferenceNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
23/02/202412h00PR Newswire (US)BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALSNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
13/02/202412h30PR Newswire (US)BrainStorm Cell Therapeutics to Present at European Life Sciences CEO ForumNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
12/02/202416h06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
18/12/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 - (NASDAQ: BCLI)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
22/11/202322h00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
27/09/202316h10AllPennyStocks.comBiotech Shares Halted Premarket As FDA Reviews ApplicationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
19/07/202315h28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
21/06/202322h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
21/06/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
20/06/202323h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
15/05/202313h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
05/04/202316h47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
10/11/202215h44TipRanksBrainstorm Plummets After the FDA Rejects ApplicationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/09/202218h45TipRanksMaxim Group Remains a Buy on Brainstorm Cell Therapeutics (BCLI)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BCLI

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
PX4
SBF 120
EU
BN
Danone
EU
ACA
Credit Agricole
NYSE
NKE
Nike
COIN
ADAUSD
Cardano
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
FTSE
UKX
FTSE 100
EU
LR
Legrand
NYSE
MRK
Merck
EU
RNO
Renault
EU
HO
Thales
EU
DG
Vinci
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés